130 related articles for article (PubMed ID: 2899227)
1. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy.
Wanders RJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM
Lancet; 1988 Jul; 2(8603):170. PubMed ID: 2899227
[No Abstract] [Full Text] [Related]
2. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; van den Bosch H; Schram AW; Tager JM
Biochem Biophys Res Commun; 1988 Jun; 153(2):618-24. PubMed ID: 3382393
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal disorders.
Gordon N
Brain Dev; 1987; 9(6):571-5. PubMed ID: 3328519
[TBL] [Abstract][Full Text] [Related]
4. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
5. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy.
Hashmi M; Stanley W; Singh I
FEBS Lett; 1986 Feb; 196(2):247-50. PubMed ID: 3948997
[TBL] [Abstract][Full Text] [Related]
6. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters.
Wanders RJ; van Roermund CW; van Wijland MJ; Nijenhuis AA; Tromp A; Schutgens RB; Brouwer-Kelder EM; Schram AW; Tager JM; van den Bosch H
Clin Chim Acta; 1987 Jun; 165(2-3):321-9. PubMed ID: 3652454
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture.
Moser HW
Neurology; 1988 Oct; 38(10):1617-27. PubMed ID: 2458548
[No Abstract] [Full Text] [Related]
8. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
Singh I; Moser AE; Goldfischer S; Moser HW
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384
[TBL] [Abstract][Full Text] [Related]
9. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency.
Lazo O; Contreras M; Bhushan A; Stanley W; Singh I
Arch Biochem Biophys; 1989 May; 270(2):722-8. PubMed ID: 2705786
[TBL] [Abstract][Full Text] [Related]
10. Adrenoleukodystrophy and Zellweger syndrome.
Moser HW; Moser AB; Chen WW; Watkins PA
Prog Clin Biol Res; 1990; 321():511-35. PubMed ID: 2183241
[No Abstract] [Full Text] [Related]
11. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
12. [Adrenoleukodystrophy].
Miyatake T
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):821-3. PubMed ID: 3270899
[No Abstract] [Full Text] [Related]
13. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
[TBL] [Abstract][Full Text] [Related]
14. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
[TBL] [Abstract][Full Text] [Related]
15. [Peroxisomal disorders; newer concept and recent studies].
Kamoshita S
Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
[No Abstract] [Full Text] [Related]
16. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
17. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy: from bedside to molecular biology.
Moser HW
J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
[TBL] [Abstract][Full Text] [Related]
19. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts.
Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW
J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.
Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
